Patent assignee · US · COMPANY

MedImmune Limited

543Patents
469Active
543Granted
62Portfolio score

Filing activity: Nov 17, 1992 → Mar 14, 2024 · 110 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7488802B2 Antibodies against PD-1 Chemistry; Metallurgy 392 Expired
US7083784B2 Molecules with extended half-lives, compositions and uses thereof Emerging Cross-Sectional Technologies 296 Expired
US5824307A Human-murine chimeric antibodies against respiratory syncytial virus Chemistry; Metallurgy 163 Expired
US8779108B2 Targeted binding agents against B7-H1 Chemistry; Metallurgy 161 Active
US7521051B2 Methods of upmodulating adaptive immune response using anti-PD-1 antibodies Chemistry; Metallurgy 156 Expired
US8409568B2 Mutant antibody Fc domains and fusion proteins thereof Chemistry; Metallurgy 85 Active
US6818216B2 Anti-RSV antibodies Chemistry; Metallurgy 84 Expired
US8309690B2 Integrated approach for generating multidomain protein therapeutics Chemistry; Metallurgy 82 Active
US8323962B2 Molecules with extended half-lives, compositions and uses thereof Emerging Cross-Sectional Technologies 75 Active
US8088905B2 Nucleic acids encoding antibodies against PD-1 Chemistry; Metallurgy 71 Active
US7704497B2 Molecules with extended half-lives, compositions and uses thereof Emerging Cross-Sectional Technologies 70 Active
US9242013B2 Targeted pyrrolobenzodiazapine conjugates Emerging Cross-Sectional Technologies 69 Active
US7566458B2 Influenza hemagglutinin and neuraminidase variants Chemistry; Metallurgy 66 Expired
US9205148B2 Antibodies and other molecules that bind B7-H1 and PD-1 Chemistry; Metallurgy 66 Active
US7658921B2 Molecules with extended half-lives, compositions and uses thereof Chemistry; Metallurgy 56 Active
US5583038A Bacterial expression vectors containing DNA encoding secretion signals of lipoproteins Emerging Cross-Sectional Technologies 56 Expired
US6656467B2 Ultra high affinity neutralizing antibodies Chemistry; Metallurgy 52 Expired
US6582706B1 Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS Human Necessities 49 Expired
US8568726B2 RSV specific binding molecule Chemistry; Metallurgy 47 Active
US8361797B2 Myeloma cell culture in transferrin-free low iron medium Chemistry; Metallurgy 47 Active
US7700735B2 High potency recombinant antibodies and method for producing them Chemistry; Metallurgy 47 Expired
US7662557B2 Methods for producing members of specific binding pairs Chemistry; Metallurgy 46 Expired
US7229619B1 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 46 Expired
US6855493B2 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment Chemistry; Metallurgy 45 Expired
US7132100B2 Stabilized liquid anti-RSV antibody formulations Chemistry; Metallurgy 39 Expired

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.